mcs110
Showing 1 - 5 of 5
Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)
Active, not recruiting
- Melanoma
- MCS110
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 14, 2022
Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)
Completed
- Triple Negative Breast Cancer
- +3 more
- MCS110
- PDR001
-
Boston, Massachusetts
- +19 more
Jul 12, 2021
Prostate Cancer, Bone Metastases Trial in Las Vegas, San Antonio (MCS110)
Terminated
- Prostate Cancer
- Bone Metastases
- MCS110
-
Las Vegas, Nevada
- +1 more
Dec 11, 2020
Pigmented Villonodular Synovitis, PVNS, Giant Cell Tumor of the Tendon Sheath Trial in Switzerland, United States (MCS110,
Completed
- Pigmented Villonodular Synovitis
- +5 more
- MCS110
- Placebo
-
San Diego, California
- +7 more
Dec 9, 2020
Breast Cancer, Cancer of Breast Trial (biological, drug, procedure)
Withdrawn
- Breast Cancer
- Cancer of Breast
- MCS110
- +6 more
- (no location specified)
Aug 14, 2018